Premium
Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis
Author(s) -
Marcella Stefanie,
Welsh Belinda,
Foley Peter
Publication year - 2011
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/j.1440-0960.2010.00660.x
Subject(s) - medicine , adalimumab , sarcoidosis , plaque psoriasis , psoriasis , dermatology , pathology , disease
A 38‐year‐old woman developed clinical, biochemical, radiological and histopathological evidence of cutaneous and pulmonary sarcoidosis 5 months after commencing adalimumab for chronic plaque psoriasis. Signs and symptoms resolved within 3 months of cessation of adalimumab.